EUROPEAN UNION - The European Chemicals Agency’s (ECHA) Board of Appeal (BOA) has rejected the appeal filed by trade group International Flavors and Fragrances (IFF) regarding the lead registrants’ dossier for hexyl salicylate.
The IFF appeal requested that the BOA annul ECHA’s request for the registrants to update their dossier with the following additional information:
- In vitro dermal absorption study
- A 28-day repeated dose toxicity study in the rat, by inhalation
- To update its Chemical Safety Report (CSR)
The trade group has pointed out that the requested information will not directly address the carcinogenic, mutagenic and reprotoxic (CMR) concerns, identified when the substance was included in the Community Rolling Action Plan (CORAP) in 2012.
The agency, on the other hand, explained that the appellant’s understanding of the CORAP substance evaluation process is “not in line with the aim, purpose and objectives of the REACH Regulation.” It added that when substances are included in the CORAP list, they have not yet been evaluated and that the concern is “indicative and not exhaustive or conclusive.”
The BOA has ruled that registrants must submit the requested information by January 27, 2017.